Review of Multimodality Management of Anaplastic Thyroid Cancer

Completed

• Conditions: Anaplastic Thyroid Cancer

• Registration Number: NCT00280852
• Lead Sponsor: Alberta Health services

Brief Summary

To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2006-01-20
• Study First Submitted QC: 2006-01-20
• Study First Posted: 2006-01-24
• Primary Completion: 2006-06
• Study Completion: 2006-06
• Status Verified: 2011-07
• Last Update Submitted: 2011-11-18
• Last Update Posted: 2011-11-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• anaplastic thyroid cancer treated with multimodality treatment

Exclusion Criteria

• differentiated thyroid cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Tom Baker Cancer Centre; 🇨🇦 Calgary, Alberta, Canada